Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 6.94557073 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.65743140 |
3 | L-phenylalanine catabolic process (GO:0006559) | 6.65743140 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.38386631 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.38386631 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 5.92660758 |
7 | epoxygenase P450 pathway (GO:0019373) | 5.71210035 |
8 | omega-hydroxylase P450 pathway (GO:0097267) | 5.56740453 |
9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36218803 |
10 | glyoxylate metabolic process (GO:0046487) | 5.31974069 |
11 | lysine catabolic process (GO:0006554) | 5.30009548 |
12 | lysine metabolic process (GO:0006553) | 5.30009548 |
13 | cysteine metabolic process (GO:0006534) | 5.28418599 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.26143932 |
15 | tryptophan catabolic process (GO:0006569) | 5.26143932 |
16 | indole-containing compound catabolic process (GO:0042436) | 5.26143932 |
17 | kynurenine metabolic process (GO:0070189) | 5.11255035 |
18 | sulfur amino acid catabolic process (GO:0000098) | 5.06006581 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04041049 |
20 | tryptophan metabolic process (GO:0006568) | 5.01187889 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99755350 |
22 | bile acid biosynthetic process (GO:0006699) | 4.94889424 |
23 | complement activation, alternative pathway (GO:0006957) | 4.84700017 |
24 | ethanol metabolic process (GO:0006067) | 4.77179183 |
25 | homocysteine metabolic process (GO:0050667) | 4.69895762 |
26 | oxidative demethylation (GO:0070989) | 4.58701706 |
27 | urea cycle (GO:0000050) | 4.54769042 |
28 | urea metabolic process (GO:0019627) | 4.54769042 |
29 | serine family amino acid catabolic process (GO:0009071) | 4.51846465 |
30 | amino-acid betaine metabolic process (GO:0006577) | 4.48046152 |
31 | protein carboxylation (GO:0018214) | 4.39290094 |
32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.39290094 |
33 | fatty acid beta-oxidation (GO:0006635) | 4.39207008 |
34 | regulation of protein activation cascade (GO:2000257) | 4.37586282 |
35 | bile acid metabolic process (GO:0008206) | 4.31779902 |
36 | negative regulation of fibrinolysis (GO:0051918) | 4.29101172 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.28719586 |
38 | triglyceride homeostasis (GO:0070328) | 4.26080260 |
39 | acylglycerol homeostasis (GO:0055090) | 4.26080260 |
40 | fatty acid oxidation (GO:0019395) | 4.23020645 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.22329559 |
42 | tyrosine metabolic process (GO:0006570) | 4.22041390 |
43 | nitrogen cycle metabolic process (GO:0071941) | 4.21512791 |
44 | acetyl-CoA metabolic process (GO:0006084) | 4.21507003 |
45 | alpha-amino acid catabolic process (GO:1901606) | 4.20264523 |
46 | regulation of complement activation (GO:0030449) | 4.17524206 |
47 | lipid oxidation (GO:0034440) | 4.14710687 |
48 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.14617858 |
49 | cellular ketone body metabolic process (GO:0046950) | 4.13172795 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 4.11625891 |
51 | plasma lipoprotein particle clearance (GO:0034381) | 4.09743543 |
52 | regulation of fibrinolysis (GO:0051917) | 4.08028586 |
53 | drug transmembrane transport (GO:0006855) | 4.07770189 |
54 | fatty acid catabolic process (GO:0009062) | 4.03724070 |
55 | cellular amino acid catabolic process (GO:0009063) | 4.00241910 |
56 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00223962 |
57 | urate metabolic process (GO:0046415) | 3.91115053 |
58 | S-adenosylmethionine metabolic process (GO:0046500) | 3.90212740 |
59 | biotin metabolic process (GO:0006768) | 3.87966090 |
60 | branched-chain amino acid catabolic process (GO:0009083) | 3.87184796 |
61 | monocarboxylic acid catabolic process (GO:0072329) | 3.86594890 |
62 | low-density lipoprotein particle clearance (GO:0034383) | 3.84256691 |
63 | cellular modified amino acid catabolic process (GO:0042219) | 3.81521956 |
64 | coenzyme catabolic process (GO:0009109) | 3.80237125 |
65 | * valine metabolic process (GO:0006573) | 3.77918889 |
66 | indolalkylamine metabolic process (GO:0006586) | 3.76875193 |
67 | organic acid catabolic process (GO:0016054) | 3.75626738 |
68 | carboxylic acid catabolic process (GO:0046395) | 3.75626738 |
69 | aspartate family amino acid catabolic process (GO:0009068) | 3.72962945 |
70 | positive regulation of lipid catabolic process (GO:0050996) | 3.71742453 |
71 | * 2-oxoglutarate metabolic process (GO:0006103) | 3.70428427 |
72 | ethanol oxidation (GO:0006069) | 3.69507479 |
73 | glutamate metabolic process (GO:0006536) | 3.69263108 |
74 | fatty acid transmembrane transport (GO:1902001) | 3.69017911 |
75 | glucuronate metabolic process (GO:0019585) | 3.67723640 |
76 | uronic acid metabolic process (GO:0006063) | 3.67723640 |
77 | serine family amino acid metabolic process (GO:0009069) | 3.66743243 |
78 | positive regulation of fatty acid oxidation (GO:0046321) | 3.66464252 |
79 | carnitine metabolic process (GO:0009437) | 3.63518747 |
80 | blood coagulation, intrinsic pathway (GO:0007597) | 3.63085657 |
81 | reverse cholesterol transport (GO:0043691) | 3.61597952 |
82 | protein-lipid complex remodeling (GO:0034368) | 3.60221149 |
83 | macromolecular complex remodeling (GO:0034367) | 3.60221149 |
84 | plasma lipoprotein particle remodeling (GO:0034369) | 3.60221149 |
85 | benzene-containing compound metabolic process (GO:0042537) | 3.59607044 |
86 | * branched-chain amino acid metabolic process (GO:0009081) | 3.57052621 |
87 | ketone body metabolic process (GO:1902224) | 3.55426977 |
88 | drug catabolic process (GO:0042737) | 3.54930763 |
89 | regulation of cholesterol homeostasis (GO:2000188) | 3.53830731 |
90 | phospholipid homeostasis (GO:0055091) | 3.52742873 |
91 | amine catabolic process (GO:0009310) | 3.51253212 |
92 | cellular biogenic amine catabolic process (GO:0042402) | 3.51253212 |
93 | arginine metabolic process (GO:0006525) | 3.50324928 |
94 | bile acid and bile salt transport (GO:0015721) | 3.49850573 |
95 | cellular glucuronidation (GO:0052695) | 3.49171651 |
96 | regulation of sequestering of triglyceride (GO:0010889) | 3.47168097 |
97 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.46168764 |
98 | regulation of cholesterol esterification (GO:0010872) | 3.45274557 |
99 | phenylpropanoid metabolic process (GO:0009698) | 3.44716033 |
100 | muscle filament sliding (GO:0030049) | 3.38647074 |
101 | actin-myosin filament sliding (GO:0033275) | 3.38647074 |
102 | negative regulation of sterol transport (GO:0032372) | 3.38602205 |
103 | negative regulation of cholesterol transport (GO:0032375) | 3.38602205 |
104 | regulation of skeletal muscle contraction (GO:0014819) | 3.38132144 |
105 | triglyceride catabolic process (GO:0019433) | 3.37626571 |
106 | glycine metabolic process (GO:0006544) | 3.37064965 |
107 | phospholipid efflux (GO:0033700) | 3.36800018 |
108 | neutral lipid catabolic process (GO:0046461) | 3.35551124 |
109 | acylglycerol catabolic process (GO:0046464) | 3.35551124 |
110 | primary alcohol metabolic process (GO:0034308) | 3.35187700 |
111 | positive regulation of glycolytic process (GO:0045821) | 3.34498448 |
112 | xenobiotic catabolic process (GO:0042178) | 3.32731662 |
113 | drug metabolic process (GO:0017144) | 3.30201956 |
114 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.28295902 |
115 | L-methionine salvage (GO:0071267) | 3.27561932 |
116 | L-methionine biosynthetic process (GO:0071265) | 3.27561932 |
117 | amino acid salvage (GO:0043102) | 3.27561932 |
118 | cytolysis (GO:0019835) | 3.26094941 |
119 | drug transport (GO:0015893) | 3.25751112 |
120 | fibrinolysis (GO:0042730) | 3.25654232 |
121 | carnitine shuttle (GO:0006853) | 3.23943961 |
122 | fatty acid homeostasis (GO:0055089) | 3.13299526 |
123 | response to nitrosative stress (GO:0051409) | 3.10792008 |
124 | arginine catabolic process (GO:0006527) | 3.05256826 |
125 | NADH metabolic process (GO:0006734) | 3.04982786 |
126 | regulation of plasminogen activation (GO:0010755) | 3.01142084 |
127 | imidazole-containing compound metabolic process (GO:0052803) | 2.98886716 |
128 | primary alcohol catabolic process (GO:0034310) | 2.98301564 |
129 | regulation of lipoprotein metabolic process (GO:0050746) | 2.97300755 |
130 | alkaloid metabolic process (GO:0009820) | 2.94375072 |
131 | brown fat cell differentiation (GO:0050873) | 2.93970643 |
132 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92163420 |
133 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92163420 |
134 | negative regulation of protein activation cascade (GO:2000258) | 2.90387910 |
135 | amino-acid betaine transport (GO:0015838) | 2.88426616 |
136 | carnitine transport (GO:0015879) | 2.88426616 |
137 | regulation of hexokinase activity (GO:1903299) | 2.86212080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.91537623 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.33093989 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.32106411 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.22493095 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87290643 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.34208954 |
7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.38514594 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91787376 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80867999 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.46163298 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.96994697 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.78333182 |
13 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.33139892 |
14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.27870620 |
15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11126061 |
16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.03428681 |
17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95557601 |
18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93161222 |
19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90233800 |
20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89736770 |
21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.87955747 |
22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86261193 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82817516 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81786772 |
25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74237634 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73833333 |
27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65362995 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43344781 |
29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41763771 |
30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40725555 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39966261 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35310453 |
33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33259255 |
34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32171253 |
35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31135403 |
36 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29192746 |
37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28223338 |
38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26973469 |
39 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26973469 |
40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26398325 |
41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25671546 |
42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24441985 |
43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24135642 |
44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23867934 |
45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23521078 |
46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22945332 |
47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21679657 |
48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19664717 |
49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19446287 |
50 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.19071091 |
51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19013251 |
52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18362613 |
53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17800983 |
54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17738271 |
55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17513156 |
56 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16156477 |
57 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15951415 |
58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15889860 |
59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14137299 |
60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12341071 |
61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11879793 |
62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11792008 |
63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10583455 |
64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08676755 |
65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07576947 |
66 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07442451 |
67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07360399 |
68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07360399 |
69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05979219 |
70 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05766745 |
71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04178563 |
72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03986663 |
73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03986663 |
74 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02810289 |
75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02763160 |
76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02595567 |
77 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01406605 |
78 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00931385 |
79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00397477 |
80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00283564 |
81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00186278 |
82 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99222741 |
83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99130215 |
84 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97741986 |
85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97388272 |
86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97388272 |
87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96845010 |
88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95768754 |
89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95766207 |
90 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.95690134 |
91 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95328780 |
92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95230533 |
93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94371691 |
94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92539382 |
95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92330694 |
96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91241895 |
97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91133605 |
98 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91007798 |
99 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89998494 |
100 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89553374 |
101 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89528947 |
102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89463155 |
103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87529825 |
104 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87297192 |
105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86971552 |
106 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86860779 |
107 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86824687 |
108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86546648 |
109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86546648 |
110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86129010 |
111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86123992 |
112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85556173 |
113 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.85533519 |
114 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84350548 |
115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82512498 |
116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81577679 |
117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80701674 |
118 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75436749 |
119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75204344 |
120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72396544 |
121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72083758 |
122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71645187 |
123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69863349 |
124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68403950 |
125 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67370246 |
126 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66517773 |
127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64809198 |
128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64374352 |
129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63974897 |
130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.62977031 |
131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.62668973 |
132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62449032 |
133 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.62383204 |
134 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.62148817 |
135 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62142217 |
136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60657400 |
137 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60501497 |
138 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60474776 |
139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60033050 |
140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59214625 |
141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58962078 |
142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.58248970 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57264569 |
144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.56843151 |
145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56807566 |
146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56036854 |
147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55722960 |
148 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54338772 |
149 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53852333 |
150 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53545476 |
151 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52895335 |
152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52639708 |
153 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52339685 |
154 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.52050671 |
155 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.51570970 |
156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51472421 |
157 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.51117793 |
158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50831625 |
159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50705942 |
160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49395146 |
161 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48448950 |
162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48267773 |
163 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.47920045 |
164 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.46179122 |
165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45846305 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.16657023 |
2 | MP0005360_urolithiasis | 6.84042007 |
3 | MP0005365_abnormal_bile_salt | 5.55020829 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.22430962 |
5 | MP0003646_muscle_fatigue | 4.47548272 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.08693456 |
7 | MP0003252_abnormal_bile_duct | 3.62099650 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.56508147 |
9 | * MP0010329_abnormal_lipoprotein_level | 3.31317136 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.21056170 |
11 | MP0005332_abnormal_amino_acid | 2.93210501 |
12 | MP0003195_calcinosis | 2.90609602 |
13 | MP0005670_abnormal_white_adipose | 2.86750402 |
14 | MP0000751_myopathy | 2.54061227 |
15 | MP0005083_abnormal_biliary_tract | 2.46839398 |
16 | MP0001666_abnormal_nutrient_absorption | 2.37679472 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.32649864 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.26219448 |
19 | MP0000749_muscle_degeneration | 2.24464348 |
20 | * MP0002118_abnormal_lipid_homeostasis | 2.22071682 |
21 | MP0009840_abnormal_foam_cell | 2.17979104 |
22 | MP0002138_abnormal_hepatobiliary_system | 2.04048878 |
23 | MP0000609_abnormal_liver_physiology | 2.02478215 |
24 | MP0004130_abnormal_muscle_cell | 1.94265442 |
25 | MP0005666_abnormal_adipose_tissue | 1.90516161 |
26 | MP0004036_abnormal_muscle_relaxation | 1.88889470 |
27 | MP0002837_dystrophic_cardiac_calcinosis | 1.87898369 |
28 | MP0009643_abnormal_urine_homeostasis | 1.78687842 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.73042674 |
30 | MP0008438_abnormal_cutaneous_collagen | 1.69220780 |
31 | * MP0005319_abnormal_enzyme/_coenzyme | 1.66937248 |
32 | MP0002638_abnormal_pupillary_reflex | 1.58916561 |
33 | MP0003868_abnormal_feces_composition | 1.53770036 |
34 | MP0004215_abnormal_myocardial_fiber | 1.52755929 |
35 | MP0001764_abnormal_homeostasis | 1.51224842 |
36 | MP0003186_abnormal_redox_activity | 1.49815449 |
37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49807473 |
38 | MP0002106_abnormal_muscle_physiology | 1.49558159 |
39 | MP0005620_abnormal_muscle_contractility | 1.48596571 |
40 | MP0005369_muscle_phenotype | 1.43562168 |
41 | MP0008775_abnormal_heart_ventricle | 1.43552174 |
42 | MP0002108_abnormal_muscle_morphology | 1.43247677 |
43 | MP0004084_abnormal_cardiac_muscle | 1.41643184 |
44 | MP0004043_abnormal_pH_regulation | 1.39824355 |
45 | MP0002971_abnormal_brown_adipose | 1.38116393 |
46 | MP0004087_abnormal_muscle_fiber | 1.36987907 |
47 | MP0002332_abnormal_exercise_endurance | 1.36583482 |
48 | MP0005375_adipose_tissue_phenotype | 1.31793327 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.30980084 |
50 | MP0001756_abnormal_urination | 1.23484316 |
51 | MP0000759_abnormal_skeletal_muscle | 1.23084457 |
52 | MP0002078_abnormal_glucose_homeostasis | 1.21156260 |
53 | MP0000013_abnormal_adipose_tissue | 1.16603708 |
54 | * MP0005334_abnormal_fat_pad | 1.16305350 |
55 | MP0000747_muscle_weakness | 1.12713622 |
56 | MP0005275_abnormal_skin_tensile | 1.09723784 |
57 | MP0004484_altered_response_of | 1.09713961 |
58 | MP0005385_cardiovascular_system_phenoty | 1.06870623 |
59 | MP0001544_abnormal_cardiovascular_syste | 1.06870623 |
60 | MP0000372_irregular_coat_pigmentation | 1.06223711 |
61 | MP0003950_abnormal_plasma_membrane | 1.06209436 |
62 | MP0005220_abnormal_exocrine_pancreas | 1.05761359 |
63 | MP0005551_abnormal_eye_electrophysiolog | 1.05393005 |
64 | * MP0005535_abnormal_body_temperature | 1.05316746 |
65 | MP0008872_abnormal_physiological_respon | 1.04815801 |
66 | * MP0005636_abnormal_mineral_homeostasis | 1.03875326 |
67 | MP0006276_abnormal_autonomic_nervous | 1.03432265 |
68 | * MP0000598_abnormal_liver_morphology | 1.03399213 |
69 | MP0006036_abnormal_mitochondrial_physio | 1.03111917 |
70 | MP0002972_abnormal_cardiac_muscle | 1.02294795 |
71 | MP0005084_abnormal_gallbladder_morpholo | 0.99943087 |
72 | MP0005451_abnormal_body_composition | 0.94772437 |
73 | MP0009115_abnormal_fat_cell | 0.94414561 |
74 | MP0005503_abnormal_tendon_morphology | 0.94350057 |
75 | MP0010368_abnormal_lymphatic_system | 0.93332205 |
76 | MP0005187_abnormal_penis_morphology | 0.93133647 |
77 | MP0005167_abnormal_blood-brain_barrier | 0.91357907 |
78 | MP0009697_abnormal_copulation | 0.91314351 |
79 | MP0002254_reproductive_system_inflammat | 0.90190050 |
80 | * MP0002876_abnormal_thyroid_physiology | 0.88298565 |
81 | MP0001986_abnormal_taste_sensitivity | 0.87734614 |
82 | MP0005379_endocrine/exocrine_gland_phen | 0.86571787 |
83 | MP0000003_abnormal_adipose_tissue | 0.86331296 |
84 | MP0005448_abnormal_energy_balance | 0.84820901 |
85 | MP0002102_abnormal_ear_morphology | 0.84330339 |
86 | * MP0009642_abnormal_blood_homeostasis | 0.83744742 |
87 | MP0005646_abnormal_pituitary_gland | 0.83037892 |
88 | MP0009763_increased_sensitivity_to | 0.81637074 |
89 | MP0002136_abnormal_kidney_physiology | 0.81017058 |
90 | MP0009780_abnormal_chondrocyte_physiolo | 0.79716109 |
91 | MP0002970_abnormal_white_adipose | 0.79708091 |
92 | MP0002168_other_aberrant_phenotype | 0.78513790 |
93 | MP0001501_abnormal_sleep_pattern | 0.77273607 |
94 | MP0009764_decreased_sensitivity_to | 0.77069376 |
95 | MP0000427_abnormal_hair_cycle | 0.76388777 |
96 | MP0003011_delayed_dark_adaptation | 0.75980132 |
97 | MP0003879_abnormal_hair_cell | 0.75811638 |
98 | MP0002928_abnormal_bile_duct | 0.74767124 |
99 | MP0000750_abnormal_muscle_regeneration | 0.72726023 |
100 | MP0000230_abnormal_systemic_arterial | 0.72501197 |
101 | MP0004272_abnormal_basement_membrane | 0.70736769 |
102 | MP0001765_abnormal_ion_homeostasis | 0.69461266 |
103 | MP0004147_increased_porphyrin_level | 0.69061071 |
104 | MP0003690_abnormal_glial_cell | 0.67841520 |
105 | * MP0003959_abnormal_lean_body | 0.67495645 |
106 | MP0003137_abnormal_impulse_conducting | 0.67388837 |
107 | MP0005376_homeostasis/metabolism_phenot | 0.67047415 |
108 | MP0004142_abnormal_muscle_tone | 0.66844646 |
109 | * MP0003953_abnormal_hormone_level | 0.64826474 |
110 | MP0005058_abnormal_lysosome_morphology | 0.64668750 |
111 | MP0001984_abnormal_olfaction | 0.64636559 |
112 | MP0003656_abnormal_erythrocyte_physiolo | 0.64383510 |
113 | MP0009384_cardiac_valve_regurgitation | 0.64355577 |
114 | MP0002060_abnormal_skin_morphology | 0.64148581 |
115 | MP0002127_abnormal_cardiovascular_syste | 0.63958336 |
116 | MP0000604_amyloidosis | 0.63712449 |
117 | * MP0008469_abnormal_protein_level | 0.62882322 |
118 | MP0003724_increased_susceptibility_to | 0.62660877 |
119 | MP0005408_hypopigmentation | 0.62474169 |
120 | MP0004085_abnormal_heartbeat | 0.62452169 |
121 | MP0002282_abnormal_trachea_morphology | 0.62139519 |
122 | MP0008961_abnormal_basal_metabolism | 0.62038876 |
123 | * MP0001944_abnormal_pancreas_morphology | 0.58413954 |
124 | MP0002796_impaired_skin_barrier | 0.55773714 |
125 | * MP0001661_extended_life_span | 0.54480683 |
126 | MP0005266_abnormal_metabolism | 0.53515315 |
127 | * MP0005647_abnormal_sex_gland | 0.52756299 |
128 | MP0005452_abnormal_adipose_tissue | 0.50474427 |
129 | MP0003300_gastrointestinal_ulcer | 0.50334580 |
130 | MP0004264_abnormal_extraembryonic_tissu | 0.50136672 |
131 | MP0002896_abnormal_bone_mineralization | 0.49885348 |
132 | MP0001881_abnormal_mammary_gland | 0.49649512 |
133 | MP0009765_abnormal_xenobiotic_induced | 0.49364554 |
134 | MP0005395_other_phenotype | 0.49019155 |
135 | MP0002295_abnormal_pulmonary_circulatio | 0.47927485 |
136 | MP0000538_abnormal_urinary_bladder | 0.45449229 |
137 | MP0005330_cardiomyopathy | 0.45202908 |
138 | MP0002269_muscular_atrophy | 0.44064813 |
139 | MP0009053_abnormal_anal_canal | 0.43823123 |
140 | MP0002909_abnormal_adrenal_gland | 0.43369291 |
141 | MP0006138_congestive_heart_failure | 0.43155346 |
142 | MP0000639_abnormal_adrenal_gland | 0.42428878 |
143 | MP0003638_abnormal_response/metabolism_ | 0.40822521 |
144 | MP0005595_abnormal_vascular_smooth | 0.39966610 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.03734613 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 5.81994242 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.77418462 |
4 | Nemaline bodies (HP:0003798) | 5.70123999 |
5 | Deep venous thrombosis (HP:0002625) | 5.56011991 |
6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.52207924 |
7 | Xanthomatosis (HP:0000991) | 5.45395041 |
8 | Hyperglycinuria (HP:0003108) | 4.97994346 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.92824771 |
10 | Ketosis (HP:0001946) | 4.84743036 |
11 | Complement deficiency (HP:0004431) | 4.80973633 |
12 | Hypoglycemic coma (HP:0001325) | 4.76516429 |
13 | Prolonged partial thromboplastin time (HP:0003645) | 4.60795640 |
14 | Abnormality of glycine metabolism (HP:0010895) | 4.57514552 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.57514552 |
16 | Hyperlipoproteinemia (HP:0010980) | 4.50292675 |
17 | Ketoacidosis (HP:0001993) | 4.43737618 |
18 | Hyperglycinemia (HP:0002154) | 4.40405291 |
19 | Hypobetalipoproteinemia (HP:0003563) | 4.40284641 |
20 | Hyperammonemia (HP:0001987) | 4.37683999 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33269991 |
22 | Exercise-induced myalgia (HP:0003738) | 4.27903928 |
23 | Type 1 muscle fiber predominance (HP:0003803) | 4.27271192 |
24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.08330385 |
25 | Epidermoid cyst (HP:0200040) | 4.01027741 |
26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.93861266 |
27 | Calf muscle hypertrophy (HP:0008981) | 3.86452029 |
28 | Hypolipoproteinemia (HP:0010981) | 3.85719581 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 3.85084389 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66261247 |
31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.63930489 |
32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.61613095 |
33 | Gout (HP:0001997) | 3.60753690 |
34 | Exercise-induced muscle cramps (HP:0003710) | 3.58287915 |
35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.57334939 |
36 | Abnormality of purine metabolism (HP:0004352) | 3.53253544 |
37 | Joint hemorrhage (HP:0005261) | 3.48255515 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44596438 |
39 | Abnormality of complement system (HP:0005339) | 3.42182009 |
40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34982363 |
41 | Fat malabsorption (HP:0002630) | 3.32608686 |
42 | Abnormality of alanine metabolism (HP:0010916) | 3.26539129 |
43 | Hyperalaninemia (HP:0003348) | 3.26539129 |
44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.26539129 |
45 | Rhabdomyolysis (HP:0003201) | 3.18723077 |
46 | Hypoglycemic seizures (HP:0002173) | 3.17583521 |
47 | Distal arthrogryposis (HP:0005684) | 3.17303720 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13698418 |
49 | Generalized aminoaciduria (HP:0002909) | 3.10049626 |
50 | Dicarboxylic aciduria (HP:0003215) | 3.07487795 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.07487795 |
52 | Abnormality of methionine metabolism (HP:0010901) | 3.07026353 |
53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.99888494 |
54 | Delayed CNS myelination (HP:0002188) | 2.99248036 |
55 | Hypercholesterolemia (HP:0003124) | 2.98898211 |
56 | Skin nodule (HP:0200036) | 2.93101493 |
57 | Abnormality of serum amino acid levels (HP:0003112) | 2.86758490 |
58 | Metabolic acidosis (HP:0001942) | 2.85777302 |
59 | Hyperuricemia (HP:0002149) | 2.85119045 |
60 | Increased purine levels (HP:0004368) | 2.85119045 |
61 | Abnormality of the calf musculature (HP:0001430) | 2.83848459 |
62 | Hyporeflexia of lower limbs (HP:0002600) | 2.83279444 |
63 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.79883742 |
64 | Myocardial infarction (HP:0001658) | 2.79115206 |
65 | Muscle fiber splitting (HP:0003555) | 2.74311549 |
66 | Proximal tubulopathy (HP:0000114) | 2.73742099 |
67 | Glomerulonephritis (HP:0000099) | 2.70707455 |
68 | Hydroxyprolinuria (HP:0003080) | 2.68069871 |
69 | Abnormality of proline metabolism (HP:0010907) | 2.68069871 |
70 | Hyperbilirubinemia (HP:0002904) | 2.67728996 |
71 | Absent phalangeal crease (HP:0006109) | 2.64109169 |
72 | EMG: myopathic abnormalities (HP:0003458) | 2.63556772 |
73 | Hepatocellular carcinoma (HP:0001402) | 2.63452374 |
74 | Lethargy (HP:0001254) | 2.60810529 |
75 | Rimmed vacuoles (HP:0003805) | 2.60154860 |
76 | Hyperglycemia (HP:0003074) | 2.57393052 |
77 | Late onset (HP:0003584) | 2.57008284 |
78 | Myopathic facies (HP:0002058) | 2.44284724 |
79 | Enlarged kidneys (HP:0000105) | 2.42396452 |
80 | Systemic lupus erythematosus (HP:0002725) | 2.40911819 |
81 | Steatorrhea (HP:0002570) | 2.40479665 |
82 | Round ear (HP:0100830) | 2.39627301 |
83 | Pancreatitis (HP:0001733) | 2.38810404 |
84 | Frequent falls (HP:0002359) | 2.37706162 |
85 | Ulnar deviation of the wrist (HP:0003049) | 2.36884174 |
86 | Symptomatic seizures (HP:0011145) | 2.35590893 |
87 | Hypertriglyceridemia (HP:0002155) | 2.34977766 |
88 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34588166 |
89 | Fair hair (HP:0002286) | 2.34247781 |
90 | Oligomenorrhea (HP:0000876) | 2.33865296 |
91 | Vomiting (HP:0002013) | 2.31353490 |
92 | Myoglobinuria (HP:0002913) | 2.31189299 |
93 | Vascular calcification (HP:0004934) | 2.30906113 |
94 | Difficulty running (HP:0009046) | 2.30743099 |
95 | Cerebral palsy (HP:0100021) | 2.30204245 |
96 | Alkalosis (HP:0001948) | 2.29722679 |
97 | Neck muscle weakness (HP:0000467) | 2.28805832 |
98 | Cerebral edema (HP:0002181) | 2.27331662 |
99 | Abnormal cartilage morphology (HP:0002763) | 2.26623478 |
100 | Cardiovascular calcification (HP:0011915) | 2.22579966 |
101 | Abnormality of the renal cortex (HP:0011035) | 2.21912459 |
102 | Bundle branch block (HP:0011710) | 2.21637603 |
103 | Heart block (HP:0012722) | 2.19431407 |
104 | Myotonia (HP:0002486) | 2.18329519 |
105 | Irritability (HP:0000737) | 2.17467545 |
106 | Abnormal finger flexion creases (HP:0006143) | 2.14645543 |
107 | Mitral stenosis (HP:0001718) | 2.13858534 |
108 | Glycosuria (HP:0003076) | 2.13725758 |
109 | Abnormality of urine glucose concentration (HP:0011016) | 2.13725758 |
110 | Hemorrhage of the eye (HP:0011885) | 2.11057109 |
111 | Neonatal onset (HP:0003623) | 2.07681442 |
112 | Asymmetric septal hypertrophy (HP:0001670) | 2.07441337 |
113 | Insulin resistance (HP:0000855) | 2.06841528 |
114 | Spastic diplegia (HP:0001264) | 2.05861578 |
115 | Sensorimotor neuropathy (HP:0007141) | 2.04980535 |
116 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04538982 |
117 | Nephritis (HP:0000123) | 2.03019680 |
118 | Abnormal gallbladder morphology (HP:0012437) | 2.02025583 |
119 | Infantile muscular hypotonia (HP:0008947) | 2.00504299 |
120 | Malnutrition (HP:0004395) | 1.99966058 |
121 | Nausea (HP:0002018) | 1.99891220 |
122 | Spontaneous abortion (HP:0005268) | 1.96992929 |
123 | Brushfield spots (HP:0001088) | 1.96145220 |
124 | Atrioventricular block (HP:0001678) | 1.94666724 |
125 | Abnormal biliary tract physiology (HP:0012439) | 1.94426518 |
126 | Bile duct proliferation (HP:0001408) | 1.94426518 |
127 | Congenital stationary night blindness (HP:0007642) | 1.93451435 |
128 | Renal cortical cysts (HP:0000803) | 1.92755010 |
129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.92469629 |
130 | Gowers sign (HP:0003391) | 1.92243726 |
131 | Abnormal atrioventricular conduction (HP:0005150) | 1.91670629 |
132 | Cholelithiasis (HP:0001081) | 1.91152455 |
133 | Acanthosis nigricans (HP:0000956) | 1.89738792 |
134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89134476 |
135 | Pigmentary retinal degeneration (HP:0001146) | 1.87187659 |
136 | Esophageal varix (HP:0002040) | 1.84525671 |
137 | Arthropathy (HP:0003040) | 1.83980248 |
138 | Increased muscle lipid content (HP:0009058) | 1.83900623 |
139 | Hepatic necrosis (HP:0002605) | 1.83140900 |
140 | Nephrolithiasis (HP:0000787) | 1.82852250 |
141 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82711074 |
142 | Subaortic stenosis (HP:0001682) | 1.82711074 |
143 | Increased serum pyruvate (HP:0003542) | 1.81720041 |
144 | Rickets (HP:0002748) | 1.80746095 |
145 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79792062 |
146 | Hypokalemic alkalosis (HP:0001949) | 1.78294141 |
147 | Opisthotonus (HP:0002179) | 1.76872680 |
148 | Pancreatic cysts (HP:0001737) | 1.76163171 |
149 | Amyloidosis (HP:0011034) | 1.72752472 |
150 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.71694505 |
151 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.71694505 |
152 | Hypochromic microcytic anemia (HP:0004840) | 1.70801407 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.97593850 |
2 | SIK1 | 4.30111815 |
3 | INSRR | 3.81759462 |
4 | ERN1 | 3.70052540 |
5 | TRIB3 | 3.38529309 |
6 | FGFR4 | 2.99088877 |
7 | CAMK1D | 2.47006039 |
8 | FRK | 2.35225591 |
9 | BMPR1B | 2.34509616 |
10 | MAPKAPK3 | 2.28890698 |
11 | MST1R | 2.19305130 |
12 | LATS1 | 2.17509665 |
13 | WNK4 | 2.05363943 |
14 | ADRBK2 | 1.99294392 |
15 | WNK3 | 1.97729724 |
16 | PKN2 | 1.90020209 |
17 | GRK1 | 1.88569064 |
18 | FLT3 | 1.78457949 |
19 | MAP4K2 | 1.77886626 |
20 | PDK4 | 1.72714397 |
21 | PDK3 | 1.72714397 |
22 | MUSK | 1.68369710 |
23 | CAMK1G | 1.67435547 |
24 | TAOK3 | 1.65641060 |
25 | ERBB4 | 1.51720739 |
26 | STK38L | 1.49346696 |
27 | NEK9 | 1.45446732 |
28 | PRKAA2 | 1.42845012 |
29 | PIK3CG | 1.42634375 |
30 | RIPK1 | 1.35668541 |
31 | FGFR2 | 1.35383045 |
32 | TRPM7 | 1.35028345 |
33 | PDGFRA | 1.34407809 |
34 | ACVR1B | 1.33010446 |
35 | MET | 1.32461689 |
36 | PTK6 | 1.31075198 |
37 | MAPK11 | 1.29341137 |
38 | EPHA3 | 1.27682435 |
39 | MAPK13 | 1.20453884 |
40 | MAP2K4 | 1.18803975 |
41 | TIE1 | 1.16754359 |
42 | TLK1 | 1.14938653 |
43 | CAMK1 | 1.11945010 |
44 | MAP2K6 | 1.11756326 |
45 | ADRBK1 | 1.10532968 |
46 | NLK | 1.09679988 |
47 | PINK1 | 1.04902171 |
48 | FGFR3 | 1.04258461 |
49 | PIK3CA | 1.00785474 |
50 | TGFBR1 | 0.98241859 |
51 | PDK2 | 0.98027766 |
52 | PRKAA1 | 0.96803962 |
53 | CASK | 0.93047559 |
54 | MAP3K7 | 0.92907224 |
55 | MAP3K3 | 0.92758696 |
56 | TGFBR2 | 0.92690822 |
57 | OXSR1 | 0.91634994 |
58 | CAMKK2 | 0.91359321 |
59 | JAK1 | 0.90714903 |
60 | ERBB3 | 0.88732485 |
61 | IRAK3 | 0.86067809 |
62 | ABL2 | 0.85657030 |
63 | TTN | 0.84209729 |
64 | MYLK | 0.81748212 |
65 | STK39 | 0.81190941 |
66 | PTK2 | 0.80717349 |
67 | PRKCE | 0.79993775 |
68 | MAP2K3 | 0.79441747 |
69 | PRKG1 | 0.79429020 |
70 | GSK3A | 0.78901839 |
71 | MAPK15 | 0.77589053 |
72 | MAP3K4 | 0.77425786 |
73 | SGK3 | 0.76311989 |
74 | FER | 0.73946570 |
75 | MARK1 | 0.73196575 |
76 | TXK | 0.72064474 |
77 | PRKACA | 0.71487360 |
78 | TYK2 | 0.69855404 |
79 | LIMK1 | 0.68359894 |
80 | NUAK1 | 0.68111804 |
81 | MAP2K1 | 0.67623696 |
82 | LMTK2 | 0.67163820 |
83 | OBSCN | 0.67058076 |
84 | PRKACG | 0.66922550 |
85 | ZAK | 0.66429226 |
86 | CDK6 | 0.65951669 |
87 | KDR | 0.65642827 |
88 | PKN1 | 0.62160785 |
89 | PAK3 | 0.61930860 |
90 | SGK223 | 0.61537653 |
91 | SGK494 | 0.61537653 |
92 | PRKCG | 0.61428919 |
93 | EPHB1 | 0.61027099 |
94 | MTOR | 0.60555419 |
95 | MAP3K2 | 0.59809651 |
96 | RET | 0.59752139 |
97 | SGK2 | 0.59509861 |
98 | GRK5 | 0.59283876 |
99 | PDPK1 | 0.57038858 |
100 | TNIK | 0.56828865 |
101 | EPHB2 | 0.56745857 |
102 | PRKCH | 0.54250861 |
103 | DYRK1B | 0.54116602 |
104 | DAPK2 | 0.52878468 |
105 | CAMK2D | 0.52876169 |
106 | PRKCZ | 0.52733323 |
107 | AKT3 | 0.51521261 |
108 | IRAK1 | 0.51429127 |
109 | PRKACB | 0.49471329 |
110 | DDR2 | 0.49208823 |
111 | KIT | 0.47300210 |
112 | * JAK2 | 0.46262186 |
113 | CAMK2A | 0.46167824 |
114 | MAPK7 | 0.46010031 |
115 | LATS2 | 0.44658646 |
116 | CAMK4 | 0.43626312 |
117 | NME1 | 0.43276850 |
118 | PHKG2 | 0.42577652 |
119 | PHKG1 | 0.42577652 |
120 | ERBB2 | 0.42095845 |
121 | PRKD1 | 0.41516517 |
122 | MAPK12 | 0.40888692 |
123 | TNK2 | 0.40659505 |
124 | PTK2B | 0.39437288 |
125 | GRK7 | 0.38004064 |
126 | RPS6KA3 | 0.37918373 |
127 | FGFR1 | 0.37650368 |
128 | STK3 | 0.37645759 |
129 | * IGF1R | 0.37627728 |
130 | MAPKAPK5 | 0.37425613 |
131 | AKT2 | 0.36333607 |
132 | PRKCA | 0.34504358 |
133 | IRAK2 | 0.34455336 |
134 | STK38 | 0.34226658 |
135 | NEK1 | 0.33600551 |
136 | MAP3K10 | 0.33562953 |
137 | NTRK3 | 0.33538529 |
138 | MAPK4 | 0.33368320 |
139 | MAP2K2 | 0.33153482 |
140 | CSK | 0.32655038 |
141 | PAK2 | 0.31841975 |
142 | DMPK | 0.31565159 |
143 | PDGFRB | 0.31205399 |
144 | ABL1 | 0.30386616 |
145 | PRKD3 | 0.30318346 |
146 | PDK1 | 0.30180937 |
147 | CSNK1D | 0.30068362 |
148 | CAMK2G | 0.28349837 |
149 | TBK1 | 0.28183256 |
150 | ROCK1 | 0.28088680 |
151 | NTRK1 | 0.27183352 |
152 | MAP3K6 | 0.27164444 |
153 | CDK9 | 0.24467361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.74413624 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15900802 |
3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.03875838 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95726605 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.85400505 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76576642 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.76333544 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70680982 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68309343 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56546087 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47764021 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37072506 |
13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.35129642 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26945900 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26922273 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.23953971 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19830391 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11166228 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09569419 |
20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.91345824 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79036016 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75369951 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74701972 |
24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58795633 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58781182 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58481926 |
27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58230596 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56383603 |
29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55948765 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55408753 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53524144 |
32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53169204 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48505544 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48445843 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43341258 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39194564 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38839175 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.38334132 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38270208 |
40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35438376 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34731938 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33454522 |
43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33031101 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30374134 |
45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24075213 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22081819 |
47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15098942 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.12013707 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09846561 |
50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08707584 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06996808 |
52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04545576 |
53 | Lysine degradation_Homo sapiens_hsa00310 | 0.98976036 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98664133 |
55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96094628 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93178416 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90129787 |
58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78958576 |
59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74080496 |
60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72754399 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69921058 |
62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68957989 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67830338 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67810923 |
65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66380663 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66290691 |
67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60053662 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.58249961 |
69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57437230 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53670844 |
71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51632607 |
72 | Phototransduction_Homo sapiens_hsa04744 | 0.45597726 |
73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44877241 |
74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44066959 |
75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41993960 |
76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39746730 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37894848 |
78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36698342 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36315003 |
80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34566823 |
81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31710691 |
82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31436009 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30519275 |
84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30438977 |
85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28369185 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28175117 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.26715871 |
88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26250370 |
89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24246310 |
90 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.23346781 |
91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20496671 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20435076 |
93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17417683 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17241795 |
95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16757800 |
96 | Renin secretion_Homo sapiens_hsa04924 | 0.16365626 |
97 | Mineral absorption_Homo sapiens_hsa04978 | 0.15968230 |
98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.15253196 |
99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15181982 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11182686 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.10589112 |
102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.10579362 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08962478 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07044588 |
105 | Insulin secretion_Homo sapiens_hsa04911 | 0.06537486 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04059323 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03589981 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.03253019 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03140377 |
110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.03127671 |
111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02437736 |
112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01578988 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1176358 |
114 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1086994 |
115 | Amoebiasis_Homo sapiens_hsa05146 | -0.1047469 |
116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0880830 |
117 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0770033 |
118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0431312 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0424560 |
120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0379114 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0220171 |
122 | Lysosome_Homo sapiens_hsa04142 | -0.0098369 |